According to Astellas Pharma's latest financial reports the company's current earnings (TTM) are A$0.24 B. In 2023 the company made an earning of A$0.18 B a decrease over its 2022 earnings that were of A$1.82 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.